Discover 3,590 paid clinical trials in Pasadena, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,590
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Location: Orange CA, Newport Beach CA, Glendale AZ, Boulder CO,
Sponsor: Nuvalent Inc.
Sex: All
Age: 18+
Code: NCT06765109
Phase 3, Recruiting
PREDICT Therapy Selection for JAK, T-cell, or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier (PREDICT)
for
Rheumatoid Arthritis
Location: Whittier CA
Sponsor: Scipher Medicine
Sex: All
Age: 18 - 70+
Code: NCT06390709
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Location: Los Angeles CA, Loma Linda CA, Portland OR, Calgary,
Sponsor: Pierre Fabre Medicament
Sex: All
Age: 0+
Code: NCT03394365
Phase 3, Recruiting
A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment
for
Primary Extra-cranial Solid Tumor,
Location: Los Angeles CA, Cincinnati OH, Atlanta GA, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 1 - 21
Code: NCT04928677
Phase 1, Recruiting
Lead-212 PSV359 Therapy for Patients With Solid Tumors
for
Pancreatic Ductal Adenocarcinoma, Gastric Cancer,
Location: Los Angeles CA, Dallas TX, Omaha NE, Kansas City KS,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06710756
Phase 1, Phase 2, Recruiting
Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
for
Recessive Dystrophic Epidermolysis Bullosa
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 7+
Code: NCT03392909
Phase 1, Phase 2, Recruiting
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
for
Epstein-Barr Virus Infections,
Location: Los Angeles CA, San Francisco CA, St Louis MO,
Sponsor: New York Medical College
Sex: All
Age: 0 - 70+
Code: NCT03266653
Phase 2, Recruiting
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
for
Bladder Carcinoma, Genitourinary System Neoplasm,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT05519878
Recruiting
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer
for
Platinum-resistant Ovarian Cancer
Location: El Segundo CA, Newport Beach CA
Sponsor: ImmunityBio, Inc.
Sex: Female
Age: 18 - 70+
Code: NCT06710288
Phase 2, Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
for
Heart Failure
Location: San Dimas CA, Santa Clarita CA, Orange CA, Tustin CA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06424288
Phase 3, Recruiting
Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
for
Opioid Use Disorder
Location: Colton CA
Sponsor: RAND
Sex: All
Age: 18+
Code: NCT06827288
Recruiting
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease